Gemcovac-19 is the first mRNA vaccine developed in India, and only the world’s third mRNA vaccine to be approved for covid-19
Listen to this article
Gennova Biopharmaceuticals, a subsidiary of Emcure Pharmaceuticals, on Wednesday announced that its mRNA vaccine Gemcovac-19 against covid-19 has received emergency use authorization (EUA) from Drugs Controller General of India (DCGI).
Recommended For You
Select your Category
Internet Not Available
Wait for it…
Log in to our website to save your bookmarks. It'll just take a moment.